For: | Kirchhoff T, Zender L, Merkesdal S, Frericks B, Malek N, Bleck J, Kubicka S, Baus S, Chavan A, Manns MP, Galanski M. Initial experience from a combination of systemic and regional chemotherapy in the treatment of patients with nonresectable cholangiocellular carcinoma in the liver. World J Gastroenterol 2005; 11(8): 1091-1095 [PMID: 15754387 DOI: 10.3748/wjg.v11.i8.1091] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v11/i8/1091.htm |
Number | Citing Articles |
1 |
Chet W. Hammill, Linda L. Wong. Intrahepatic Cholangiocarcinoma: A Malignancy of Increasing Importance. Journal of the American College of Surgeons 2008; 207(4): 594 doi: 10.1016/j.jamcollsurg.2008.04.031
|
2 |
Charles E. Ray, Anthony Edwards, Mitchell T. Smith, Stephen Leong, Kimi Kondo, Matthew Gipson, Paul J. Rochon, Rajan Gupta, Wells Messersmith, Tom Purcell, Janette Durham. Metaanalysis of Survival, Complications, and Imaging Response following Chemotherapy-based Transarterial Therapy in Patients with Unresectable Intrahepatic Cholangiocarcinoma. Journal of Vascular and Interventional Radiology 2013; 24(8): 1218 doi: 10.1016/j.jvir.2013.03.019
|
3 |
S. Herber, G. Otto, J. Schneider, N. Manzl, I. Kummer, S. Kanzler, A. Schuchmann, J. Thies, C. Düber, M. Pitton. Transarterial Chemoembolization (TACE) for Inoperable Intrahepatic Cholangiocarcinoma. CardioVascular and Interventional Radiology 2007; 30(6): 1156 doi: 10.1007/s00270-007-9032-7
|
4 |
M. Knüppel, S. Kubicka, A. Vogel, N. P. Malek, M. Schneider, F. Papendorf, T. Greten, J. Wedemeyer, A. Schneider. Combination of Conservative and Interventional Therapy Strategies for Intra- and Extrahepatic Cholangiocellular Carcinoma: A Retrospective Survival Analysis. Gastroenterology Research and Practice 2012; 2012: 1 doi: 10.1155/2012/190708
|
5 |
Satoru Seo, Etsuro Hatano, Tatsuya Higashi, Akio Nakajima, Yuji Nakamoto, Masaharu Tada, Nobuyuki Tamaki, Keiko Iwaisako, Akira Mori, Ryuichiro Doi, Iwao Ikai, Shinji Uemoto. Fluorine-18 fluorodeoxyglucose positron emission tomography predicts lymph node metastasis, P-glycoprotein expression, and recurrence after resection in mass-forming intrahepatic cholangiocarcinoma. Surgery 2008; 143(6): 769 doi: 10.1016/j.surg.2008.01.010
|
6 |
Kerri A. Simo, Laura E. Halpin, Nicole M. McBrier, Jacob A. Hessey, Erin Baker, Samuel Ross, Ryan Z. Swan, David A. Iannitti, John B. Martinie. Multimodality treatment of intrahepatic cholangiocarcinoma: A review. Journal of Surgical Oncology 2016; 113(1): 62 doi: 10.1002/jso.24093
|
7 |
Melanie B. Thomas. Biological characteristics of cancers in the gallbladder and biliary tract and targeted therapy. Critical Reviews in Oncology/Hematology 2007; 61(1): 44 doi: 10.1016/j.critrevonc.2006.07.006
|
8 |
Tomáš Andrašina, Vlastimil Válek, Jiří Pánek, Zdeněk Kala, Igor Kiss, Štěpán Tuček, Pavel Šlampa. Multimodal Oncological Therapy Comprising Stents, Brachytherapy, and Regional Chemotherapy for Cholangiocarcinoma. Gut and Liver 2010; 4(Suppl.1): S82 doi: 10.5009/gnl.2010.4.S1.S82
|
9 |
Danish Mazhar, Justin Stebbing, Mark Bower. Chemotherapy For Advanced Cholangiocarcinoma: What Is Standard Treatment?. Future Oncology 2006; 2(4): 509 doi: 10.2217/14796694.2.4.509
|
10 |
Pankaj Singh, Tushar Patel. Advances in the diagnosis, evaluation and management of cholangiocarcinoma. Current Opinion in Gastroenterology 2006; 22(3): 294 doi: 10.1097/01.mog.0000218967.60633.64
|
11 |
Kelvin Hong, Jean-Francois H. Geschwind. Locoregional Intra-arterial Therapies for Unresectable Intrahepatic Cholangiocarcinoma. Seminars in Oncology 2010; 37(2): 110 doi: 10.1053/j.seminoncol.2010.03.002
|
12 |
Yucel Ustundag, Yusuf Bayraktar. Cholangiocarcinoma: A compact review of the literature. World Journal of Gastroenterology 2008; 14(42): 6458-6466 doi: 10.3748/wjg.14.6458
|
13 |
Peter Huppert, Nikolas Kortes, Clemens Kratochwil, Boris Radeleff, Anne Schmitz, Ulrike Stampfl. Angiofibel. 2021; : 409 doi: 10.1007/978-3-662-56243-7_14
|
14 |
Matthew V. Kiefer, Marissa Albert, Madeline McNally, Mary Robertson, Weijing Sun, Douglas Fraker, Kim Olthoff, Kathleen Christians, Sam Pappas, William Rilling, Michael C. Soulen. Chemoembolization of intrahepatic cholangiocarcinoma with cisplatinum, doxorubicin, mitomycin C, ethiodol, and polyvinyl alcohol. Cancer 2011; 117(7): 1498 doi: 10.1002/cncr.25625
|
15 |
Alfredo Guglielmi, Andrea Ruzzenente, Calogero Iacono. Surgical Treatment of Hilar and Intrahepatic Cholangiocarcinoma. Updates in Surgery 2008; : 233 doi: 10.1007/978-88-470-0729-1_23
|
16 |
Thomas J. Ettrich, Thomas Seufferlein. Locoregional Tumor Therapy. 2018; : 107 doi: 10.1007/978-3-319-69947-9_5
|
17 |
Sebastian Mondaca, Hooman Yarmohammadi, Nancy E. Kemeny. Regional Chemotherapy for Biliary Tract Tumors and Hepatocellular Carcinoma. Surgical Oncology Clinics of North America 2019; 28(4): 717 doi: 10.1016/j.soc.2019.06.008
|
18 |
C. Margarit, A. Escartín, J. Bellmunt, E. Allende, I. Bilbao. Colangiocarcinoma periférico: resultados del tratamiento quirúrgico. Gastroenterología y Hepatología 2006; 29(4): 215 doi: 10.1157/13085990
|
19 |
Niraj J. Gusani, Fady K. Balaa, Jennifer L. Steel, David A. Geller, J. Wallis Marsh, Albert B. Zajko, Brian I. Carr, T. Clark Gamblin. Treatment of Unresectable Cholangiocarcinoma with Gemcitabine-Based Transcatheter Arterial Chemoembolization (TACE): A Single-Institution Experience. Journal of Gastrointestinal Surgery 2008; 12(1): 129 doi: 10.1007/s11605-007-0312-y
|
20 |
Lara Maria Pasetto, Mario Rosario D’Andrea, Cristina Falci, Silvio Monfardini. Gemcitabine in advanced biliary tract cancers. Critical Reviews in Oncology/Hematology 2007; 61(3): 230 doi: 10.1016/j.critrevonc.2006.04.006
|
21 |
Fabian Goerg, Markus Zimmermann, Philipp Bruners, Ulf Neumann, Tom Luedde, Christiane Kuhl. Chemoembolization with Degradable Starch Microspheres for Treatment of Patients with Primary or Recurrent Unresectable, Locally Advanced Intrahepatic Cholangiocarcinoma: A Pilot Study. CardioVascular and Interventional Radiology 2019; 42(12): 1709 doi: 10.1007/s00270-019-02344-0
|
22 |
Eun-Young Kim, Sang Soo Lee, Ji Hoon Shin, Soo Hyun Kim, Dong-Ho Shin, Seung Yon Baek. Anticancer effect of arsenic trioxide on cholangiocarcinoma: in vitro experiments and in vivo xenograft mouse model. Clinical and Experimental Medicine 2014; 14(2): 215 doi: 10.1007/s10238-013-0233-x
|
23 |
Thomas Ettrich, Thomas Seufferlein. Locoregional Tumor Therapy. 2015; : 73 doi: 10.1007/978-3-642-36572-0_6
|
24 |
Guo Wei, Ming-Ming Nie, Xiao-Jun Shen, Xu-Chao Xue, Li-Ye Ma, Cheng-Hui Du, Shi-Liang Wang, Jian-Wei Bi. Experimental Study on Sustained-release 5-Fluorouracil Implantation in Canine Peritoneum and Para-aortic Abdominalis. Asian Pacific Journal of Cancer Prevention 2014; 15(1): 407 doi: 10.7314/APJCP.2014.15.1.407
|
25 |
Thomas J. Vogl, Nagy N.N. Naguib, Nour‐Eldin A. Nour‐Eldin, Wolf O. Bechstein, Stefan Zeuzem, Jörg Trojan, Tatjana Gruber‐Rouh. Transarterial chemoembolization in the treatment of patients with unresectable cholangiocarcinoma: Results and prognostic factors governing treatment success. International Journal of Cancer 2012; 131(3): 733 doi: 10.1002/ijc.26407
|
26 |
Ron C. Gaba, R. Peter Lokken, Ryan M. Hickey, Andrew J. Lipnik, Robert J. Lewandowski, Riad Salem, Daniel B. Brown, T. Gregory Walker, James E. Silberzweig, Mark Otto Baerlocher, Ana Maria Echenique, Mehran Midia, Jason W. Mitchell, Siddharth A. Padia, Suvranu Ganguli, Thomas J. Ward, Jeffrey L. Weinstein, Boris Nikolic, Sean R. Dariushnia. Quality Improvement Guidelines for Transarterial Chemoembolization and Embolization of Hepatic Malignancy. Journal of Vascular and Interventional Radiology 2017; 28(9): 1210 doi: 10.1016/j.jvir.2017.04.025
|
27 |
Jan B. Kuhlmann, Wulf Euringer, Hans C. Spangenberg, Matthias Breidert, Hubert E. Blum, Jan Harder, Richard Fischer. Treatment of unresectable cholangiocarcinoma. European Journal of Gastroenterology & Hepatology 2012; : 1 doi: 10.1097/MEG.0b013e3283502241
|